What is the share price of Pfizer Ltd (PFIZER) today?
The share price of PFIZER as on 11th July 2025 is ₹5499.50. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Pfizer Ltd (PFIZER) share?
The past returns of Pfizer Ltd (PFIZER) share are- Past 1 week: -1.06%
- Past 1 month: 0.27%
- Past 3 months: 35.67%
- Past 6 months: 4.18%
- Past 1 year: 9.07%
- Past 3 years: 32.13%
- Past 5 years: 33.83%
What are the peers or stocks similar to Pfizer Ltd (PFIZER)?
The peers or stocks similar to Pfizer Ltd (PFIZER) include:What is the dividend yield % of Pfizer Ltd (PFIZER) share?
The current dividend yield of Pfizer Ltd (PFIZER) is 3.01.What is the market cap of Pfizer Ltd (PFIZER) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Pfizer Ltd (PFIZER) is ₹25042.31 Cr as of 11th July 2025.What is the 52 week high and low of Pfizer Ltd (PFIZER) share?
The 52-week high of Pfizer Ltd (PFIZER) is ₹6451.15 and the 52-week low is ₹3701.What is the PE and PB ratio of Pfizer Ltd (PFIZER) stock?
The P/E (price-to-earnings) ratio of Pfizer Ltd (PFIZER) is 32.62. The P/B (price-to-book) ratio is 5.94.Which sector does Pfizer Ltd (PFIZER) belong to?
Pfizer Ltd (PFIZER) belongs to the Health Care sector & Pharmaceuticals sub-sector.How to buy Pfizer Ltd (PFIZER) shares?
You can directly buy Pfizer Ltd (PFIZER) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Pfizer Ltd
PFIZER Share Price
5,499.500.47% (+25.50)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
PFIZER Stock Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
GoodThe stock is underpriced and is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
PFIZER Performance & Key Metrics
PFIZER Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 32.62 | 5.94 | 3.01% |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 36.59 | 6.40 | 0.79% |
100%
Analysts have suggested that investors can buy this stock
from 3 analysts
Price Upside
Earnings Growth
Rev. Growth
PFIZER Company Profile
Pfizer Limited is a pharmaceutical company. The Company has a portfolio of approximately 140 products across over 15 therapeutic areas.
SUNPHARMA
PE Ratio
36.50
36.50
1Y Return
4.00%
4.00%
Buy Reco %
87.10
87.10
CIPLA
PE Ratio
22.64
22.64
1Y Return
2.34%
2.34%
Buy Reco %
73.33
73.33
TORNTPHARM
PE Ratio
59.13
59.13
1Y Return
13.13%
13.13%
Buy Reco %
70.83
70.83
DRREDDY
PE Ratio
18.58
18.58
1Y Return
4.24%
4.24%
Buy Reco %
51.72
51.72
MANKIND
PE Ratio
52.73
52.73
1Y Return
18.31%
18.31%
Buy Reco %
81.25
81.25
PFIZER Forecast
PFIZER Forecasts
Price
Revenue
Earnings
PFIZER Share Price Forecast
PFIZER Share Price Forecast
2025
Current
₹5,474.00
Baseline
Forecast for Jul 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹
2025
Current
₹5,474.00
Baseline
Forecast for Jul 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹
PFIZER Company Revenue Forecast
PFIZER Company Revenue Forecast
2025
Current
₹2.63
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹ Thousand cr.
2025
Current
₹2.63
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹ Thousand cr.
PFIZER Stock EPS (Earnings Per Share) Forecast
PFIZER Stock EPS (Earnings Per Share) Forecast
2025
Current
₹167.78
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹
2025
Current
₹167.78
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹
PFIZER
PFIZER
Income
Balance Sheet
Cash Flow
Annual Normal View
PFIZER Income Statement
PFIZER Income Statement
Annual Normal View
| Financial Year | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 2,197.85 | 2,082.80 | 2,248.89 | 2,335.67 | 2,319.67 | 2,673.64 | 2,558.81 | 2,381.63 | 2,626.41 | 2,626.41 | ||||||||||
Raw Materials | 812.24 | 712.17 | 838.78 | 829.02 | 783.39 | 1,020.93 | 817.19 | 804.39 | 785.09 | 1,541.12 | ||||||||||
| Power & Fuel Cost | 10.34 | 12.34 | 11.45 | 11.04 | 5.79 | 5.67 | 6.51 | 3.98 | 3.48 | |||||||||||
| Employee Cost | 303.89 | 314.29 | 323.84 | 364.51 | 361.06 | 403.67 | 331.68 | 347.80 | 371.33 | |||||||||||
| Selling & Administrative Expenses | 383.12 | 316.73 | 335.32 | 319.66 | 268.67 | 310.77 | 298.03 | 317.96 | 260.05 | |||||||||||
| Operating & Other expenses | 106.54 | 112.34 | 6.48 | 54.70 | 107.24 | 34.01 | 162.40 | 83.72 | 121.08 | |||||||||||
EBITDA | 581.72 | 614.93 | 733.02 | 756.74 | 793.52 | 898.59 | 943.00 | 823.78 | 1,085.38 | 1,085.29 | ||||||||||
| Depreciation/Amortization | 62.93 | 66.25 | 71.39 | 103.24 | 109.41 | 115.00 | 105.51 | 62.28 | 60.79 | 60.79 | ||||||||||
| PBIT | 518.79 | 548.68 | 661.63 | 653.50 | 684.11 | 783.59 | 837.49 | 761.50 | 1,024.59 | 1,024.50 | ||||||||||
| Interest & Other Items | 1.96 | 0.77 | 1.72 | 11.01 | 15.39 | 10.70 | 13.48 | 15.43 | 8.50 | 8.41 | ||||||||||
| PBT | 516.83 | 547.91 | 659.91 | 642.49 | 668.72 | 772.89 | 824.01 | 746.07 | 1,016.09 | 1,016.09 | ||||||||||
| Taxes & Other Items | 180.05 | 187.84 | 230.86 | 133.36 | 171.11 | 160.33 | 200.08 | 194.74 | 248.49 | 248.49 | ||||||||||
| Net Income | 336.78 | 360.07 | 429.05 | 509.13 | 497.61 | 612.56 | 623.93 | 551.33 | 767.60 | 767.60 | ||||||||||
| EPS | 73.61 | 78.70 | 93.78 | 111.28 | 108.76 | 133.88 | 136.37 | 120.50 | 167.78 | 167.78 | ||||||||||
| DPS | 20.00 | 20.00 | 22.50 | 330.00 | 35.00 | 35.00 | 70.00 | 35.00 | 165.00 | 35.00 | ||||||||||
| Payout ratio | 0.27 | 0.25 | 0.24 | 2.97 | 0.32 | 0.26 | 0.51 | 0.29 | 0.98 | 0.21 |
PFIZER Company Updates
PFIZER Stock Peers
PFIZER Past Performance & Peer Comparison
PFIZER Past Performance & Peer Comparison
Comparing 3 stocks from
Health CarePharmaceuticals
Compare valuation-basic on Screener
Health CarePharmaceuticals
Valuation
Technical
Forecast
Compare valuation-basic on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Pfizer Ltd | 32.62 | 5.94 | 3.01% |
| Sun Pharmaceutical Industries Ltd | 36.50 | 5.50 | 0.96% |
| Cipla Ltd | 22.64 | 3.82 | 1.08% |
| Torrent Pharmaceuticals Ltd | 59.13 | 14.89 | 0.18% |
PFIZER Stock Price Comparison
Compare PFIZER with any stock or ETFCompare PFIZER with any stock or ETF
PFIZER
PFIZER Holdings
PFIZER Shareholdings
PFIZER Promoter Holdings Trend
PFIZER Promoter Holdings Trend
Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
PFIZER Institutional Holdings Trend
PFIZER Institutional Holdings Trend
Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has almost stayed constant
PFIZER Shareholding Pattern
PFIZER Shareholding Pattern
PFIZER Shareholding History
PFIZER Shareholding History
Foreign Institutions
Mutual Funds Invested in PFIZER
Mutual Funds Invested in PFIZER
No mutual funds holding trends are available
Top 5 Mutual Funds holding Pfizer Ltd
| Funds (Top 5) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
|---|---|---|---|---|
The rupee value of the stock held by the fund divided by the stock’s market cap 2.7344% | Percentage of the fund’s portfolio invested in the stock 1.03% | Change in the portfolio weight of the stock over the last 3 months 0.16% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 104/248 (-2) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 1.9838% | Percentage of the fund’s portfolio invested in the stock 1.68% | Change in the portfolio weight of the stock over the last 3 months 0.27% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 67/119 (-1) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 0.9171% | Percentage of the fund’s portfolio invested in the stock 3.04% | Change in the portfolio weight of the stock over the last 3 months 0.71% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 13/49 (+7) |
Compare 3-month MF holding change on Screener
Hmm, looks like there hasn't been any net deal activity in the last 6 monthssmallcases containing PFIZER stock
smallcases containing PFIZER stock
Looks like this stock is not in any smallcase yet.
PFIZER Events
PFIZER Events
PFIZER Dividend Trend
No Dividend Cuts
Dividends are the portion of earnings that a company distributes to all its shareholders every year
PFIZER has increased or maintained dividend levels over the last 5 years
Dividend Yield
Dividend return is one of the most important things to be considered while investing for long term. It is the additional return on top of what investors earn through price appreciation
Current dividend yield is 3.01%. An investment of ₹1,000 in the stock is expected to generate dividend of ₹30.14 every year
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
PFIZER Dividend Trend
No Dividend Cuts
Dividends are the portion of earnings that a company distributes to all its shareholders every year
PFIZER has increased or maintained dividend levels over the last 5 years
Dividend Yield
Dividend return is one of the most important things to be considered while investing for long term. It is the additional return on top of what investors earn through price appreciation
Current dividend yield is 3.01%. An investment of ₹1,000 in the stock is expected to generate dividend of ₹30.14 every year
PFIZER Upcoming Dividends
PFIZER Upcoming Dividends
No upcoming dividends are available
PFIZER Past Dividends
PFIZER Past Dividends
Cash Dividend
Ex DateEx DateJul 9, 2025
Special
Special | Div/Share: ₹30.00
Dividend/Share
₹30.00
Ex DateEx Date
Jul 9, 2025
Cash Dividend
Ex DateEx DateJul 9, 2025
Final
Final | Div/Share: ₹35.00
Dividend/Share
₹35.00
Ex DateEx Date
Jul 9, 2025
Cash Dividend
Ex DateEx DateAug 21, 2024
Final
Final | Div/Share: ₹35.00
Dividend/Share
₹35.00
Ex DateEx Date
Aug 21, 2024
Cash Dividend
Ex DateEx DateAug 11, 2023
Special
Special | Div/Share: ₹5.00
Dividend/Share
₹5.00
Ex DateEx Date
Aug 11, 2023
Cash Dividend
Ex DateEx DateAug 11, 2023
Final
Final | Div/Share: ₹35.00
Dividend/Share
₹35.00
Ex DateEx Date
Aug 11, 2023
PFIZER Stock News & Opinions
PFIZER Stock News & Opinions
Articles & Videos
Corporate
Pfizer to hold AGM
Pfizer announced that the 74th Annual General Meeting(AGM) of the company will be held on 21 July 2025.Powered by Capital Market - Live
1 month agoCapital Market - Live
Spotlight
Volumes jump at Pfizer Ltd counter
BASF India Ltd, NLC India Ltd, Zensar Technologies Ltd, Newgen Software Technologies Ltd are among the other stocks to see a surge in volumes on NSE today, 20 May 2025.Pfizer Ltd witnessed volume of 12.07 lakh shares by 14:14 IST on NSE, a 75.73 times surge over two-week average daily volume of 15933 shares. The stock increased 10.90% to Rs.4,955.00. Volumes stood at 15028 shares in the last session.BASF India Ltd clocked volume of 7.26 lakh shares by 14:14 IST on NSE, a 15.18 times surge over two-week average daily volume of 47859 shares. The stock gained 8.17% to Rs.5,303.70. Volumes stood at 1.38 lakh shares in the last session.NLC India Ltd clocked volume of 167.99 lakh shares by 14:14 IST on NSE, a 14.61 times surge over two-week average daily volume of 11.50 lakh shares. The stock gained 2.14% to Rs.241.50. Volumes stood at 14.63 lakh shares in the last session.Zensar Technologies Ltd notched up volume of 131.18 lakh shares by 14:14 IST on NSE, a 13.13 fold spurt over two-week average daily volume of 9.99 lakh shares. The stock rose 6.37% to Rs.837.45. Volumes stood at 5.08 lakh shares in the last session.Newgen Software Technologies Ltd recorded volume of 57.45 lakh shares by 14:14 IST on NSE, a 10.05 times surge over two-week average daily volume of 5.72 lakh shares. The stock gained 9.64% to Rs.1,258.30. Volumes stood at 6.61 lakh shares in the last session.Powered by Capital Market - Live
1 month agoCapital Market - Live
Spotlight
Pfizer gallops after good Q4 outcome
Pfizer reported and exceptional profit of Rs 172.81 crore in Q4 March 2025, primarily due to the completion of the sale and transfer of its Thane facility to Zoetis Pharmaceutical Research. Sequentially, the company's adjusted net profit surged 55.43% while net sales jumped 10.02% in Q4 FY25 over Q3 FY25. Profit before tax and exceptional items stood at Rs 252.99 crore in Q4 FY25, up 3.74% year-on-year and up 46.71% QoQ. For the full year, adjusted net profit rose 17.28% to Rs 639.71 crore while net sales increased 4.02% to Rs 2,281.35 crore in the year ended March 2025 over the year ended March 2024. Profit before tax and exceptional items rose 14.25% year-on-year to Rs 843.28 crore in FY25 over FY24. The company's net cash from operating activities stood at Rs 659.75 crore in FY25, higher than Rs 256.84 crore in FY24. The company's board recommended a final dividend of Rs 35 per equity share, a special dividend of Rs 100 per equity share in view of 75th year of Pfizer in India and a special dividend of Rs 30 per equity share in view of the gain on transfer of assignment of leasehold land and building constructed on such land thereon, totaling to a dividend of Rs 165 per equity share for FY25. The company has fixed 9 July 2025, as the record date. Pfizer is engaged in manufacturing, marketing, trading and export of pharmaceutical products. Powered by Capital Market - Live
1 month agoCapital Market - Live
Corporate
Board of Pfizer recommends final dividend
Pfizer announced that the Board of Directors of the Company at its meeting held on 19 May 2025, inter alia, have recommended the final dividend of Rs 35 per equity Share (i.e. 350%) , subject to the approval of the shareholders.Powered by Capital Market - Live
1 month agoCapital Market - Live
Corporate
Board of Pfizer recommends special dividend
Pfizer announced that the Board of Directors of the Company at its meeting held on 19 May 2025, inter alia, have recommended the special dividend of Rs 100 per equity Share (i.e. 1000%) , subject to the approval of the shareholders.Powered by Capital Market - Live
1 month agoCapital Market - Live
Corporate
Board of Pfizer recommends special dividend
75th year of Pfizer announced that the Board of Directors of the Company at its meeting held on 19 May 2025, inter alia, have recommended the special dividend of Rs 30 per equity Share (i.e. 300%) , subject to the approval of the shareholders.Powered by Capital Market - Live
1 month agoCapital Market - Live
Earnings
Pfizer standalone net profit rises 85.03% in the March 2025 quarter
Net profit of Pfizer rose 85.03% to Rs 330.94 crore in the quarter ended March 2025 as against Rs 178.86 crore during the previous quarter ended March 2024. Sales rose 8.28% to Rs 591.91 crore in the quarter ended March 2025 as against Rs 546.63 crore during the previous quarter ended March 2024. For the full year,net profit rose 39.23% to Rs 767.60 crore in the year ended March 2025 as against Rs 551.33 crore during the previous year ended March 2024. Sales rose 4.02% to Rs 2281.35 crore in the year ended March 2025 as against Rs 2193.17 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales591.91546.63 8 2281.352193.17 4 OPM %38.4334.65 -32.4528.97 - PBDT269.39257.61 5 904.07800.40 13 PBT252.99243.86 4 843.28738.12 14 NP330.94178.86 85 767.60551.33 39 Powered by Capital Market - Live
1 month agoCapital Market - Live
Corporate
Pfizer schedules board meeting
Pfizer will hold a meeting of the Board of Directors of the Company on 19 May 2025.Powered by Capital Market - Live
1 month agoCapital Market - Live
Spotlight
Volumes spurt at Pfizer Ltd counter
Triveni Engineering and Industries Ltd, Century Plyboards (India) Ltd, 360 ONE WAM Ltd, Data Patterns (India) Ltd are among the other stocks to see a surge in volumes on NSE today, 24 February 2025.Pfizer Ltd notched up volume of 9.3 lakh shares by 14:14 IST on NSE, a 18.12 fold spurt over two-week average daily volume of 51359 shares. The stock rose 5.50% to Rs.4,320.35. Volumes stood at 16716 shares in the last session.Triveni Engineering and Industries Ltd notched up volume of 23.57 lakh shares by 14:14 IST on NSE, a 6.64 fold spurt over two-week average daily volume of 3.55 lakh shares. The stock rose 1.89% to Rs.385.00. Volumes stood at 4.36 lakh shares in the last session.Century Plyboards (India) Ltd notched up volume of 26.98 lakh shares by 14:14 IST on NSE, a 4.54 fold spurt over two-week average daily volume of 5.95 lakh shares. The stock slipped 0.03% to Rs.771.20. Volumes stood at 37.38 lakh shares in the last session.360 ONE WAM Ltd recorded volume of 23.65 lakh shares by 14:14 IST on NSE, a 3.83 times surge over two-week average daily volume of 6.18 lakh shares. The stock gained 4.84% to Rs.1,028.70. Volumes stood at 4.82 lakh shares in the last session.Data Patterns (India) Ltd notched up volume of 24.05 lakh shares by 14:14 IST on NSE, a 3.2 fold spurt over two-week average daily volume of 7.52 lakh shares. The stock rose 4.43% to Rs.1,622.50. Volumes stood at 9.46 lakh shares in the last session.Powered by Capital Market - Live
4 months agoCapital Market - Live
Spotlight
Volumes spurt at Pfizer Ltd counter
Century Plyboards (India) Ltd, L&T Technology Services Ltd, Tata Consultancy Services Ltd, AAVAS Financiers Ltd are among the other stocks to see a surge in volumes on BSE today, 24 February 2025.Pfizer Ltd registered volume of 14873 shares by 10:48 IST on BSE, a 6.97 fold spurt over two-week average daily volume of 2134 shares. The stock rose 6.73% to Rs.4,370.00. Volumes stood at 1532 shares in the last session.Century Plyboards (India) Ltd recorded volume of 36095 shares by 10:48 IST on BSE, a 1.86 times surge over two-week average daily volume of 19370 shares. The stock gained 4.61% to Rs.806.15. Volumes stood at 1.32 lakh shares in the last session.L&T Technology Services Ltd notched up volume of 6418 shares by 10:48 IST on BSE, a 1.79 fold spurt over two-week average daily volume of 3576 shares. The stock slipped 5.44% to Rs.4,841.90. Volumes stood at 5194 shares in the last session.Tata Consultancy Services Ltd clocked volume of 1.44 lakh shares by 10:48 IST on BSE, a 1.72 times surge over two-week average daily volume of 83609 shares. The stock lost 1.77% to Rs.3,718.70. Volumes stood at 89843 shares in the last session.AAVAS Financiers Ltd recorded volume of 5714 shares by 10:48 IST on BSE, a 1.61 times surge over two-week average daily volume of 3552 shares. The stock lost 0.45% to Rs.1,683.25. Volumes stood at 3418 shares in the last session.Powered by Capital Market - Live
4 months agoCapital Market - Live
Over the last 5 years, revenue has grown at a yearly rate of 2.37%, vs industry avg of 10.1%
Over the last 5 years, market share decreased from 0.93% to 0.63%
Over the last 5 years, net income has grown at a yearly rate of 8.56%, vs industry avg of 20.04%